Text
Researchers have found that certain gut bacteria and their metabolites differ between IBS subtypes.
Results of a recent study showed reduced microbial diversity and distinct microbial profile in the two groups of PC patients.
Changes in gut bacteria, especially Akkermansia, could predict treatment success in people with lung cancer.
Ethical, long-term partnerships can uncover valuable scientific insights while respecting Indigenous knowledge.
Controlling cadaverine levels and the gut bacteria that produce it could help regulate immune cell metabolism and inflammation.
Immunology
Sponsored by
Three infant-derived strains isolated and developed by Coree srl that are potentially interesting for immune support.
Environments and social factors shape human microbiotas.
The abundance of Bifidobacterium may explain M116’s excellent cholesterol profile and low inflammation levels.
MaaT Pharma, based in Lyon and listed on Euronext Paris, unveiled the final results of its ARES Phase 3 trial of Xervyteg® (MaaT013).
New IPA Europe analysis puts hard numbers on how evidence-based probiotic use could cut healthcare costs and boost productivity across the EU.
